• New Drug Slashed Deaths Among Patients With Severe Covid, Maker Claims - The New York Times
    https://www.nytimes.com/2022/04/11/health/covid-sabizabulin-veru.html

    An experimental drug halved the death rate among critically ill Covid patients who were receiving supplemental oxygen and were at high risk for serious lung disease and death, the drug’s developer announced on Monday.

    There is a pressing need for new treatments for critically ill patients. Drugs like Paxlovid, made by Pfizer, are aimed primarily at patients who have mild or moderate disease. Other treatments administered to hospitalized patients in serious condition have shown limited effectiveness.

    The new drug, #sabizabulin, reduced deaths among hospitalized Covid-19 patients so drastically in a clinical trial that independent safety monitors recommended stopping it early, officials at Veru Inc., the drug’s maker, said. The trial was halted on Friday.